Breaking AI & Tech News Analyzed

A recent experiment with an autonomous AI agent, named Gaskell, has provided a glimpse into the capabilities and limitations of these emerging technologies. Gaskell, created by a team of individuals, was tasked with organizing a party in Manchester, which the author attended.Gaskell's autonomous nature was put to the test as it interacted with potential sponsors and event staff, showcasing both impressive abilities and significant limitations. The AI agent was able to secure a venue, arrange for catering, and even attempt to negotiate with vendors, although it ultimately failed to deliver on some promises, such as ordering pizza.The event itself was surprisingly ordinary, with around 50 attendees engaging in discussions about AI over beers and snacks. Despite some initial missteps, including a failed attempt to secure a venue at the Manchester Art Gallery, Gaskell's human employees were able to step in and ensure the event's success.Gaskell's limitations were evident in its inability to use a phone or credit card, highlighting the current constraints of autonomous AI agents. However, the experiment also demonstrated the potential for these technologies to autonomously manage complex tasks and interact with humans in meaningful ways.The author notes that Gaskell's capabilities, although imperfect, represent a significant step forward in AI development, and that similar experiments are likely to become more common in the future.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The Artemis II crew has made contact from space, marking a crucial step in their mission. While details of the communication are scarce, the achievement underscores the progress of NASA's Artemis program aimed at returning humans to the Moon.The crew's ability to establish communication from space highlights the advancements in space technology and the resilience of the spacecraft's systems. This development is a positive indicator for the mission's overall success and future endeavors in space exploration.

NASA's Artemis II mission has reached a critical phase as the four astronauts on board have successfully fired up their spacecraft's engine to break away from Earth's orbit and embark on a trajectory towards the moon. This historic moment marks the first crewed lunar flyby in over half a century. The Orion capsule's engine blasted off on Thursday, propelling the astronauts on their 10-day mission, which includes looping around the moon. The burn, lasting just under six minutes, provided enough thrust to accelerate a stationary car to highway-driving speed in less than three seconds. The mission control team in Houston confirmed the successful burn, stating, 'Looks like a good burn, we're confirming.' The astronauts, consisting of Americans Reid Wiseman, Victor Glover, and Christina Koch, along with Canadian Jeremy Hansen, are now on a 'free return' trajectory, utilizing the moon's gravity to slingshot around it before heading back towards Earth without propulsion. The Artemis II mission is a crucial step towards establishing a permanent human presence on the moon, with the ultimate goal of landing humans on the lunar surface by 2028. This mission also marks a series of historic firsts, including the first person of color, the first woman, and the first non-American on a lunar mission. The spacecraft's crew spent their initial hours in space performing checks and troubleshooting minor issues, including a communications problem and a malfunctioning toilet. They also began their fitness routine on the spacecraft's 'flywheel exercise device' to minimize muscle and bone loss in microgravity. NASA's Artemis program has been portrayed as a competitive effort with China, which aims to land humans on the moon by 2030. The program has faced pressure from various quarters, including former President Trump, who has pushed for an accelerated pace. The mission's commander, Reid Wiseman, described the breathtaking view of Earth from space, saying, 'You can see the entire globe from pole to pole... It was the most spectacular moment and it paused all four of us in our tracks.'

A plush toy designed by eight-year-old Lucas Ye from California has become an unlikely participant in NASA's Artemis II mission, the agency's first crewed lunar mission in over 50 years. The toy, named Rise, serves as a zero-gravity indicator and was included in the mission after Lucas won a global competition.Rise is a smiley-faced plush toy wearing a baseball cap with a star-spangled visor and a crown resembling Earth's surface. Lucas's design was chosen from over 2,600 entrants in a competition presided over by NASA and Freelancer, a crowdsourcing company.The Artemis II mission, which launched on Wednesday, aims to send astronauts farther from Earth than any humans in history. The crew will travel over 250,000 miles into space and back over a period of 10 days. If successful, the mission will pave the way for future lunar exploration, including the 2028 scheduled mission to place humans back on the moon.Rise's journey is not without precedent; similar zero-gravity indicator objects have been part of space missions in the past. Lucas's achievement is a significant milestone for the young space enthusiast, who aspires to work at NASA or become an astrophysicist.The Artemis II mission also marks a historic moment for diversity in space exploration, with a woman, Christina Koch, and a person of color, Victor Glover, flying between Earth's orbit and the moon for the first time.

NASA's Artemis II space mission has successfully launched from Florida, embarking on a historic journey around the moon with four astronauts on board. This mission marks a significant milestone in the United States space agency's plan to return humans to the moon and eventually send astronauts to Mars.The 32-storey rocket rose from NASA's Kennedy Space Center in Cape Canaveral, where tens of thousands gathered to witness the liftoff. The Artemis II crew, consisting of NASA astronauts Reid Wiseman, Victor Glover, and Christina Koch, and Canadian Space Agency astronaut Jeremy Hansen, are set for a nearly 10-day journey around the moon and back.“On this historic mission, you take with you the heart of this Artemis team, the daring spirit of the American people and our partners across the globe, and the hopes and dreams of a new generation,” said Charlie Blackwell-Thompson, the launch director. “Good luck, Godspeed Artemis II. Let’s go.”During the mission, the astronauts will spend the first one to two days in high Earth orbit carrying out extensive systems checks. They will then perform a critical engine burn known as translunar injection, which will send the spacecraft out of Earth's orbit and onto a trajectory towards the moon.The journey will take several days, during which the crew will continue monitoring spacecraft systems as they travel farther from Earth. Orion will then fly behind the moon on a free-return trajectory, a path that naturally swings the spacecraft back towards Earth using the gravity of both the moon and Earth, with minimal fuel required.After the lunar flyby, the crew will spend several days traveling back to Earth while carrying out additional deep-space tests on power systems, thermal controls, and crew operations. As Orion approaches Earth, the capsule will re-enter the atmosphere at speeds of about 40,233km per hour (25,000 miles per hour), before splashing down in the Pacific Ocean, where recovery teams will retrieve the crew.

NASA's Artemis II mission is on track to make history as four astronauts prepare to leave Earth's orbit and embark on a journey towards the moon. This 10-day voyage marks a significant milestone in the US space agency's ambitious plan to land humans back on the lunar surface this decade and establish a permanent presence there.The crew, consisting of three Americans and one Canadian, launched from the Kennedy Space Center in Florida on Wednesday. After a series of tests and preparations, they are set to perform a translunar injection burn, a six-minute engine firing that will send the Orion spacecraft on its path to the moon.During their journey, the astronauts will loop around the back of the moon, becoming the four people to travel the farthest from Earth in history. They will then use the moon's gravity to launch back home. This mission is expected to break the record for distance traveled away from Earth, currently held by the Apollo 13 crew, who reached 248,655 miles (400,171km) in 1970.The Artemis II mission is a crucial test of NASA's capabilities, with future missions aiming to land astronauts on the moon's south pole as early as 2028. The US is in a new space race with China, which plans to send a crewed mission to the same lunar region as early as 2030. NASA's long-term goal is to build a lunar base that can house a permanent human presence, bringing humanity closer to living on the moon and Mars.

NASA's highly anticipated Artemis II mission successfully lifted off from the Kennedy Space Center on April 2, 2026. This mission represents a crucial step forward in the agency's ambitious plans for space exploration.The Artemis program aims to return humans to the lunar surface by 2025 and establish a sustainable presence on the Moon. The Artemis II mission is an uncrewed flight test of the Space Launch System (SLS) rocket and the Orion spacecraft, which will eventually carry astronauts to the Moon.The launch from Kennedy Space Center's Pad 39B marks a significant milestone in the development of the SLS rocket and the Orion spacecraft. This mission will test the spacecraft's systems and prepare the way for future crewed missions.

The countdown at Kennedy Space Center is in its final stages for the Artemis II launch, the first crewed lunar mission since 1972. NASA Associate Administrator Amit Kshatriya confirmed after a Monday management meeting that the mission is cleared for a Wednesday liftoff. Launch window: A two‑hour window opens at 6:24 pm (22:24 GMT) on Wednesday, with daily two‑hour windows remaining available until April 6. The launch can proceed only when the moon’s position, orbital trajectories, weather, and Earth’s rotation align safely. Weather outlook: Forecasts show an 80 % chance of favorable conditions, though cloud cover and high winds remain the primary concerns. The mission has already endured two major setbacks. In early February a liquid‑hydrogen leak forced a scrub, and in early March a helium‑flow issue in the upper stage halted a second attempt. NASA will stream the launch live on YouTube, where viewers can follow the vehicle from rollout to liftoff. Artemis programme overview: Artemis is NASA’s multidecade effort to return humans to the Moon, establish a sustainable presence near the lunar south pole, and eventually enable crewed missions to Mars. The program comprises five missions (Artemis I‑V). Artemis I, an uncrewed test in 2022, validated the Space Launch System (SLS) and Orion spacecraft, providing critical data for the current flight. Mission profile: Artemis II will not land; instead, its four‑person crew will perform a lunar flyby, looping around the far side before returning to Earth. The flight will test Orion’s life‑support, navigation, communications, and overall performance in deep space—conditions that cannot be fully replicated on the ground. Crew members: Reid Wiseman (Commander, 50) – veteran NASA astronaut and former ISS commander. Victor Glover (Pilot, 49) – U.S. Navy aviator, first Black astronaut assigned to a lunar mission, previously flew on SpaceX Crew‑1. Christina Koch (Mission Specialist, 47) – holds the record for the longest single spaceflight by a woman (328 days) and has extensive EVA experience. Jeremy Hansen (Mission Specialist, 50) – Canada’s first astronaut slated for a lunar mission, highlighting international collaboration. During the ten‑day journey the crew will evaluate spacecraft systems, conduct radiation and fire‑response drills, perform a suit‑pressurisation test, and carry out medical and scientific experiments while observing the lunar surface. Strategic importance: Artemis II is a stepping stone toward Artemis III (planned for 2027), which will test integrated operations with commercial landers, followed by Artemis IV (early 2028) – the first crewed lunar landing since Apollo 17 – and Artemis V (late 2028) aimed at establishing a lunar base. The program also reinforces U.S. leadership in space amid rising competition, notably from China.